AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Invesco Ltd.

Invesco Ltd. increased its position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 12.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,433,172 shares of the company's stock after purchasing an additional 155,838 shares during the period. Invesco Ltd. owned 1.07% of AdaptHealth worth $13,644,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Bank of Montreal Can boosted its holdings in shares of AdaptHealth by 13.1% in the 4th quarter. Bank of Montreal Can now owns 28,558 shares of the company's stock valued at $272,000 after buying an additional 3,299 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of AdaptHealth by 36.1% during the fourth quarter. Wells Fargo & Company MN now owns 54,546 shares of the company's stock worth $519,000 after acquiring an additional 14,460 shares during the last quarter. Foundry Partners LLC raised its position in AdaptHealth by 6.5% in the 4th quarter. Foundry Partners LLC now owns 804,011 shares of the company's stock valued at $7,654,000 after purchasing an additional 48,804 shares during the last quarter. Geode Capital Management LLC boosted its stake in AdaptHealth by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock worth $23,499,000 after purchasing an additional 16,596 shares during the period. Finally, Segall Bryant & Hamill LLC grew its position in AdaptHealth by 29.8% during the 4th quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock worth $45,734,000 after purchasing an additional 1,102,173 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Trading Up 4.7 %

NASDAQ:AHCO traded up $0.38 on Friday, reaching $8.41. The stock had a trading volume of 1,656,371 shares, compared to its average volume of 1,246,423. The firm's fifty day moving average is $9.59 and its two-hundred day moving average is $9.88. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The company has a market cap of $1.13 billion, a price-to-earnings ratio of -5.10, a P/E/G ratio of 1.08 and a beta of 1.44. AdaptHealth Corp. has a 12-month low of $7.11 and a 12-month high of $11.90.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on AHCO shares. Robert W. Baird increased their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. UBS Group decreased their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Truist Financial lifted their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Royal Bank of Canada increased their price objective on AdaptHealth from $11.00 to $14.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Finally, Canaccord Genuity Group lifted their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $13.80.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.